Navigation Links
Cord Blood America CEO Matthew Schissler Discusses Projects in China, South America, 'Afford-A-Cord,' and Profitability
Date:9/16/2010

LAS VEGAS, Sept. 16 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that Matthew Schissler, its co-founder and CEO, was interviewed by analyst Francis Gaskins on the Company's current accomplishments and future business strategies.

The entire interview is available at:

http://gaskinsco.com/cbai-9-15-10.mp3

  • Progress continues in China, with expectations that a temporary laboratory will be in place this year and the processing of samples can begin in 2010,  which will derive revenues for Cord Blood America.  The major, permanent, state-of-the-art laboratory being constructed there will be completed in two – three years.
  • The Company will close its acquisition of controlling interest in BioCells, Inc., Buenos Aires, Argentina, shortly.  "Argentina is a fast growing market and gives us the opportunity to expand throughout South and Central America," Mr. Schissler said.  Also, because the company is profitable, the acquisition will produce positive results for Cord Blood America from the first day.  Mr. Schissler said significant translation issues with a large number of documents slowed the process from an August closing.
  • "Afford-A-Cord," which Cord Blood America announced with fanfare in June, which allows families to store their baby's umbilical cord blood at a significantly reduced rate at the time of birth, has increased in sales each month it has been offered.  Mr. Schissler said there is an educational process involved but the Company is very encouraged by results up to this time.
  • The collection of placentas by CBAI for a major tissue bank in the U.S. now accounts for five percent of the Company's revenues, with significant growth expected.  "We will continue to focus on adding other revenue diversification programs, which reduces risk and makes our revenue model more secure," Mr. Schissler said.
  • Finally, Cord Blood America's CEO said, "Profitability is the Company's number one goal and, once profitable, this will open up larger and better opportunities for CBAI's future."

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

CONTACT:

Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com




'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation to Launch Warrant Exchange Offer
2. China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results
3. Cord Blood America Says Outreach Program to OB/GYN Nurses, Insurance Case Workers, Paying Significant Dividends
4. New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments
5. Cord Blood America CEO Updates Investors on Financial Developments and Stem Cell News in Interview
6. Cord Blood America Reports 12% Increase in 2010 Second Quarter Revenue
7. China Cord Blood Corporation Announces Cancellation of Nine Million Management Incentive Warrants
8. China Cord Blood Corporation Joins Russell Global Index
9. Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors
10. Leading Cord Blood Experts Clarify Their Support of CORD:USE Family Cord Blood Bank
11. Scientists Give the Go-Ahead for Private Storage of Stem Cells From Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
Breaking Biology Technology:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
Breaking Biology News(10 mins):